AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Sanofi-Aventis to keep U.S. research headquarters in Malvern, Pa.

The Philadelphia Inquirer (Philadelphia, PA)

| September 28, 2004 | COPYRIGHT 2004 The Philadelphia Inquirer. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Byline: Linda Loyd

Sep. 28--Sanofi-Aventis, the world's third-largest pharmaceutical company, will keep its U.S. research and drug development headquarters in Malvern, a company official said yesterday.

The 750 scientists and researchers at the Great Valley Corporate Center in Malvern were part of Sanofi-Synthelabo SA, the French drug maker which in August bought larger rival Aventis SA for $61.9 billion.

Sanofi and Aventis agreed in April to combine after Sanofi raised its takeover offer.

"Great Valley is going to stay where it is" as a U.S. research and drug development center, said company spokesman Marc Greene, who said details on ...

Related articles from newspapers, magazines, journals, and more
Sanofi-aventis Statement.
Press release article from: PR Newswire June 3, 2005 700+ words
...During the Shareholders Meeting of sanofi-aventis held May 31, 2005, the Chairman...Board of Directors discussed sanofi-aventis's position with regard to Rhodia...not a strategic investment for sanofi-aventis and as a result, sanofi- aventis...
Sanofi-aventis Completes Acquisition of Merck's Interest in Merial.
Press release article from: Business Wire September 18, 2009 700+ words
...WHITEHOUSE STATION, N.J. -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY...announced that the acquisition by sanofi-aventis of Merck's 50 percent interest...Merial) has been completed. Sanofi-aventis acquired Merck's interest in...
Sanofi-aventis Concludes Euro 10 Billion in Medium-Term Credit Agreements With...
Press release article from: PR Newswire April 1, 2005 700+ words
...PRNewswire-FirstCall/ -- Sanofi-aventis announced today the simultaneous...billion tranche A facility, allow sanofi-aventis to refinance substantially all...operations significantly reduce sanofi-aventis' credit costs. About sanofi...
Sanofi-aventis 'Solidarity Day' Offers Additional Aid, Assistance to Southeast...
Press release article from: PR Newswire January 25, 2005 700+ words
'Sharing in Solidarity' Sanofi-aventis today is organizing a solidarity day in 300 sanofi-aventis sites worldwide to allow Group...selected in close consultation with sanofi-aventis teams and managers in the stricken...
Sanofi-aventis Issues Strong Support for Voluntary 'Guiding Principles' on DTC...
Press release article from: PR Newswire August 2, 2005 700+ words
...pharmaceutical operating entities of the sanofi-aventis Group, are strongly committed...member companies, including sanofi-aventis. "We believe that this approach...and Chief Executive Officer of sanofi-aventis in the United States. Experience...
Sanofi-Aventis Sues Novopharm for Patent Infringement in Canada.
Press release article from: PR Newswire March 11, 2005 700+ words
Sanofi-aventis has learned through the Canadian Ministry...claiming to be generic enoxaparin. Sanofi-aventis companies Aventis Pharma Inc. and...2045433, which covers Lovenox(R). Sanofi-aventis will vigorously defend its legal rights...
Sanofi-aventis Annual General Meeting.
Press release article from: PR Newswire May 31, 2005 700+ words
...The Annual General Meeting of sanofi-aventis shareholders was held on May...period. The Board of Directors of sanofi-aventis in its meeting held after the...shares representing 1.15% of sanofi- aventis share capital, held by the Group...
Sanofi-aventis and Regeneron Pharmaceuticals Reaffirm Development Commitment.
Press release article from: PR Newswire January 10, 2005 700+ words
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced...in combination with chemotherapy. Sanofi-aventis also announced that Regeneron has earned...are looking forward to working with sanofi-aventis to accelerate the development of the...
For more facts and information, see all results

Source: HighBeam Research, Sanofi-Aventis to keep U.S. research headquarters in Malvern, Pa.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA